Status:
COMPLETED
Effect of Timolol on Refractive Outcomes in Eyes With Myopic Regression After LASIK: a Randomized Clinical Trial
Lead Sponsor:
Shahid Beheshti University of Medical Sciences
Conditions:
Myopic Regression
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
In this randomized controlled clinical trial, we compare the effects of timolol versus placebo for treatment of myopic regression after LASIK
Eligibility Criteria
Inclusion
- Patients with myopic regression equal or more than 0.5 D with minimum age of 20 years,
- cylinder ≤ -1.00 D,
- corrected distance visual acuity (CDVA) of at least 20/40 were included.
Exclusion
- Patients with a history of previous ocular surgery,
- keratoconus or any ectatic corneal disorder,
- keratoconus suspect by topography,
- preoperative corneal opacity,
- any corneal dystrophies,
- presence of pterygium,
- retinal disorders,
- collagen vascular disorders,
- diabetes mellitus,
- glaucoma,
- cataract,
- pregnancy,
- breast feeding
- systemic corticosteroid therapy were excluded.
Key Trial Info
Start Date :
March 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT01506635
Start Date
March 1 2010
End Date
December 1 2010
Last Update
January 10 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ophthalmic Research Center
Tehran, Tehran Province, Iran, 16666